Structure via PubChem · Public domain (PubChem)
ganciclovir
Sign in to saveAlso known as Vitrasert, GA2, 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one, Ganciclovirum, 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one, 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol, Gancyclovir
Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections.
Chemical data
- Formula
- C9H13N5O4
- Molecular weight
- 255.23 g/mol
- IUPAC name
- 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one
- SMILES
- C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N
- InChIKey
- IRSCQMHQWWYFCW-UHFFFAOYSA-N
- XLogP
- -2.5
- Polar surface area
- 135 Ų
- H-bond donors
- 4
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
Wikidata facts
- Mass
- 255.097
Show 4 more facts
- Commons category
- Ganciclovir
- chemical formula
- C₉H₁₃N₅O₄
- World Health Organisation international non-proprietary name
- ganciclovir
- canonical SMILES
- C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
Sources (8)
via Wikidata · CC0
~4 min read
Article
10 sectionsContents
- Medical use
- Veterinary use
- Adverse effects
- Toxicity
- Mechanism of action
- Pharmacokinetics
- Administration
- See also
- References
- Further reading
Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections.
Ganciclovir was patented in 1980 and approved for medical use in 1988.
Connections
antiviral drug
Entity
neomycin
Entity
nucleoside analogue
Entity
International Standard Book Number
Entity
kidney
Entity
antibiotic
Entity
anemia
Entity
digital object identifier
Entity
infection
Entity
chemical formula
Entity
melting point
Entity
hepatitis B
Entity
ophthalmology
Entity
chemotherapy
Entity
urea
Entity
hematology
Entity
adenine
Entity
human papillomavirus infection
Entity
peptide
Entity
molar mass
Entity